{
    "Trade/Device Name(s)": [
        "Dimension Creatinine (CRE2) Flex reagent cartridge",
        "Dimension\u00ae Creatinine (CRE2) Flex\u00ae reagent cartridge"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K132638",
    "Predicate Device Reference 510(k) Number(s)": [
        "K925668"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGX"
    ],
    "Summary Letter Date": "November 13, 2013",
    "Summary Letter Received Date": "November 14, 2013",
    "Submission Date": "August 22, 2013",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension clinical chemistry system"
    ],
    "Method(s)/Technology(ies)": [
        "Modified kinetic Jaffe technique",
        "Photometric detection (510, 600 nm)"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Creatinine (CRE2) Flex reagent cartridge using modified kinetic Jaffe method for quantifying creatinine in serum, plasma, and urine.",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative measurement of creatinine in human serum, plasma, and urine to aid in diagnosis and treatment of renal disease, monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.",
    "fda_folder": "Clinical Chemistry"
}